160 results on '"Craig, Andrew W."'
Search Results
2. Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes
3. Advancing cancer immunotherapy: from innovative preclinical models to clinical insights
4. Fes-deficient macrophages enhance CD8+T cell priming and tumour control through increased proinflammatory cytokine production and presentation
5. Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes
6. 544 Coordinated blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector memory responses
7. Toward a Template for Synthetic Actin-Targeting Macrolide Analogues That Inhibit Cancer Cell Invasiveness.
8. CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer
9. Supplementary Figures S1-7 from Endophilin A2 Promotes TNBC Cell Invasion and Tumor Metastasis
10. Effects of Modulating Actin Dynamics on HER2 Cancer Cell Motility and Metastasis
11. Estrogen mediates inflammatory role of mast cells in endometriosis pathophysiology
12. Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT
13. Wild-type p53 suppresses formin-binding protein-17 (FBP17) to reduce invasion
14. STAT5A is regulated by DNA damage via the tumor suppressor p53
15. Al-Bahlul and the Court of Military Commission Review: is there a place for conspiracy in the international law of armed conflict?
16. Truncated Actin-Targeting Macrolide Derivative Blocks Cancer Cell Motility and Invasion of Extracellular Matrix
17. Mast cells enhance sterile inflammation in chronic nonbacterial osteomyelitis
18. Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models
19. Interaction of polyadenylate-binding protein with the eIF4G homologue PAIP enhances translation
20. MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinoma
21. Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
22. Abstract 3960: Tumor cell drug resistance induced by the programmed death ligand 1 (PD-L1) immune checkpoint is associated with autophagy
23. STAT1‐associated intratumoural TH1 immunity predicts chemotherapy resistance in high‐grade serous ovarian cancer
24. Abstract 2179: Macrolide toxin Mycalolide B is a potent inhibitor of HER2 cancer cell invasion and is the basis of actin targeted therapy for metastatic cancers
25. Dataset of STAT5A status in breast cancer
26. Abstract 3106: Elucidating molecular mechanisms linking microRNA-206 loss to tumor progression and metastasis
27. Endophilin A2 Promotes TNBC Cell Invasion and Tumor Metastasis
28. Editorial: Leukocyte-targeting toxins as therapeutics in allergic asthma
29. Abstract 4053: Formin-binding protein-17 (FBP17) is a target of p53 and promotes invadopodia formation in breast cancer cells
30. SHP2 Phosphatase Promotes Mast Cell Chemotaxis toward Stem Cell Factor via Enhancing Activation of the Lyn/Vav/Rac Signaling Axis
31. Calpains promote neutrophil recruitment and bacterial clearance in an acute bacterial peritonitis model
32. Abstract 3796: Endophilin II promotes breast tumor progression and metastasis.
33. Abstract 787: Tumor suppressor p53 inhibits expression of the pro-metastasis protein Toca-1.
34. Fer Kinase Limits Neutrophil Chemotaxis toward End Target Chemoattractants
35. SH2 Domain-Containing Phosphatase 2 Is a Critical Regulator of Connective Tissue Mast Cell Survival and Homeostasis in Mice
36. The Family Infighting Continues: Dualling Src Family Kinases Now Linked to Activating IgG Receptor Signaling and Anaphylaxis
37. The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor
38. Cdc42-interacting protein 4 is a Src substrate that regulates invadopodia and invasiveness of breast tumors by promoting MT1-MMP endocytosis
39. Abstract 3832: Defining molecular mechanisms controlling FES activation and microtubule binding as a potential strategy to limit mast cell recruitment to tumors via the SCF/KIT axis
40. SH2 Domain-Containing Phosphatase-2 Protein-Tyrosine Phosphatase Promotes FcεRI-Induced Activation of Fyn and Erk Pathways Leading to TNFα Release from Bone Marrow-Derived Mast Cells
41. Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin αVβ3
42. Contributions of F-BAR and SH2 Domains of Fes Protein Tyrosine Kinase for Coupling to the FcεRI Pathway in Mast Cells
43. Involvement of Fyn kinase in Kit and integrin-mediated Rac activation, cytoskeletal reorganization, and chemotaxis of mast cells
44. Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis.
45. Continuous association of cadherin with β-catenin requires the non-receptor tyrosine-kinase Fer
46. Actin depolymerization-induced tyrosine phosphorylation of cortactin: the role of Fer kinase
47. Fer Kinase Is Required for Sustained p38 Kinase Activation and Maximal Chemotaxis of Activated Mast Cells
48. Absence of Fer Protein-Tyrosine Kinase Exacerbates Leukocyte Recruitment in Response to Endotoxin
49. Mice Devoid of Fer Protein-Tyrosine Kinase Activity Are Viable and Fertile but Display Reduced Cortactin Phosphorylation
50. Translational Repression by a Novel Partner of Human Poly(A) Binding Protein, Paip2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.